These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1551275)

  • 1. Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis.
    Carmassi F; Morale M; Puccetti R; Pistelli F; Palla R; Bevilacqua G; Viacava P; Antonelli A; Mariani G
    Clin Exp Rheumatol; 1992; 10(1):13-7. PubMed ID: 1551275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.
    Kaveri SV; Dietrich G; Hurez V; Kazatchkine MD
    Clin Exp Immunol; 1991 Nov; 86(2):192-8. PubMed ID: 1934588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune chronic active hepatitis].
    Renner EL
    Ther Umsch; 1993 Feb; 50(2):100-9. PubMed ID: 8456413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intravenous immunoglobulin therapy of serious autoimmune rheumatic diseases.
    Lukan N; Lazurova I; Racz O; Kristofova B; Tkac I
    Bratisl Lek Listy; 2008; 109(11):489-92. PubMed ID: 19205557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful treatment of chronic active hepatitis with high-dose intravenous immunoglobulins in agammaglobulinemia].
    Bejaoui M; Gharbi A; Bouguerra A; Dellagi K; Lakhoua R
    Arch Pediatr; 1994 Feb; 1(2):158-61. PubMed ID: 7987443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.
    Yu Z; Lennon VA
    N Engl J Med; 1999 Jan; 340(3):227-8. PubMed ID: 9895405
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic active autoimmune hepatitis: review of the current treatment].
    Garassini S MA
    Rev Gastroenterol Mex; 1995; 60(4 Suppl 2):S65-7. PubMed ID: 8948786
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin and autoimmune disease.
    El-Shanawany T; Jolles S
    Ann N Y Acad Sci; 2007 Sep; 1110():507-15. PubMed ID: 17911466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease.
    Heintges T; Niederau C
    Z Gastroenterol; 1993 May; 31(5):285-8. PubMed ID: 7686702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders.
    Omwandho CO; Gruessner SE; Roberts TK; Tinneberg HR
    Clin Chem Lab Med; 2004 Apr; 42(4):359-70. PubMed ID: 15147144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.
    Li N; Zhao M; Hilario-Vargas J; Prisayanh P; Warren S; Diaz LA; Roopenian DC; Liu Z
    J Clin Invest; 2005 Dec; 115(12):3440-50. PubMed ID: 16284651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenous immunoglobulin treatment in autoimmune diseases].
    Danieli MG; Calcabrini L; Marchetti A; Calabrese V; Pettinari L; Massaccesi C; Gabrielli A; Danieli G
    Recenti Prog Med; 2007 Jun; 98(6):322-6. PubMed ID: 17580523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin therapy for autoimmune diseases.
    Arnson Y; Shoenfeld Y; Amital H
    Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.
    Fuchs S; Feferman T; Zhu KY; Meidler R; Margalit R; Wang N; Laub O; Souroujon MC
    Ann N Y Acad Sci; 2007 Sep; 1110():550-8. PubMed ID: 17911471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.